Ion Exchange (India) Ltd (BOM:500214) Q2 2025 Earnings Call Highlights: Strong Revenue Growth ...

Published 2024-11-17, 08:00 p/m
Ion Exchange (India) Ltd (BOM:500214) Q2 2025 Earnings Call Highlights: Strong Revenue Growth ...

GuruFocus - Release Date: November 15, 2024

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

  • Ion Exchange (India) Ltd (BOM:500214) reported a 21% year-on-year increase in operating income for Q2 2025, reaching INR 6,445 million.
  • The company's EBITA increased by 13% year-on-year, with a margin of 10.5%.
  • Net profit rose by 19% year-on-year to INR 506 million, with a profit margin of 7.85%.
  • The engineering division saw a 26% year-on-year revenue increase, driven by improved execution of large EPC contracts.
  • The chemical division reported a 12% year-on-year revenue increase, with a 23% rise in EBITA, indicating strong performance and margin improvement.
Negative Points
  • The consumer product division continues to experience losses, with a loss of INR 35 million for the quarter.
  • Capacity utilization in the chemical segment is between 65-70%, indicating underutilization of existing capacity.
  • The company faces challenges in the execution of certain contracts, impacting overall margins.
  • There is uncertainty regarding the allocation of funds for projects in Sri Lanka, affecting the completion of contracts.
  • The company's overall operating profit margin remains at 11%, with no significant improvement expected due to ongoing contract challenges.
Q & A Highlights Q: Can you provide an update on the chemical segment's commercialization and preparations for ramping up production?

A: We have been preparing for the launch of the new plant by establishing long-term contracts with key customers and building relationships with distribution channels globally. We are confident that within 3 to 4 years, we will achieve full capacity utilization. (Respondent: Unidentified_5)

Q: What is the current capacity utilization in the chemical segment, and why isn't it fully utilized?

A: Our current capacity utilization is between 65-70%. The capacity is based on a specific product mix, and we are optimizing for both top-line and bottom-line growth. We expect a 5-10% increase in utilization with changes in the product mix. (Respondent: Unidentified_5)

Q: How is the engineering segment performing, and what are the expectations for the future?

A: The engineering segment has seen a ramp-up, and we expect revenue growth to continue. We anticipate a 15-20% growth in the current year, driven by improved execution of contracts and a strong order book. (Respondent: Unidentified_5)

Q: Can you comment on the insider selling of shares by key individuals?

A: The sale of shares by the individuals mentioned is a personal decision. They have been long-term investors and are selling a small portion of their holdings, likely to monetize their investments. (Respondent: Unidentified_5)

Q: What is the status of the Sri Lanka contract and the associated receivables?

A: The Sri Lanka contract is progressing slowly, with further execution dependent on fund allocation. There is still some outstanding amount, but we are confident about recovering it once funds are allocated. (Respondent: Unidentified_5)

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

This content was originally published on Gurufocus.com

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.